Shujing Liang
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Orthopedics and Sports Medicine top 10%
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Bone Metabolism and Diseases 3
-
- Cancer Cells and Metastasis 2
- Cancer-related Molecular Pathways 2
-
- Additive Manufacturing Materials and Processes 2
- Journals
- International Journal of Molecular Sciences (3 papers)Acta Astronautica (1 paper)RSC Advances (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Shujing Liang
18 papers receiving 686 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 201
- Orthopedics and Sports Medicine 68
- Molecular Biology 425
- Physiology 131
- Oncology 134
Countries citing papers authored by Shujing Liang
This map shows the geographic impact of Shujing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujing Liang more than expected).
Fields of papers citing papers by Shujing Liang
This network shows the impact of papers produced by Shujing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujing Liang. The network helps show where Shujing Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shujing Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 83 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 41 | |
| 11 | 2020 | 47 | |
| 12 | 2020 | 187 | |
| 13 | 2020 | 50 | |
| 14 | 2019 | 54 | |
| 15 | MT1JP inhibits tumorigenesis and enhances cisplatin sensitivity of breast cancer cells through competitively binding to miR-24-3p. | 2019 | 15 |
| 16 | 2019 | 3 | |
| 17 | 2016 | 82 | |
| 18 | 2015 | 19 | |
| 19 | 2014 | 62 | |
| 20 | 2014 | 1 |
About Shujing Liang
Shujing Liang is a scholar working on Cancer Research, Orthopedics and Sports Medicine and Molecular Biology, having authored 20 papers that have together received 692 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), Bone Metabolism and Diseases (3 papers), Additive Manufacturing Materials and Processes (2 papers), Cancer Cells and Metastasis (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (201 citations), Orthopedics and Sports Medicine (68 citations) and Molecular Biology (425 citations). Shujing Liang has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Lifang Hu, Airong Qian, Zixiang Wu, Zhihao Chen, Abdul S. Qadir, Shuyu Liu, Xia Xu, Zhihao Chen, Fengchun Zhang and Yanyun Zhang. Their work appears in journals such as International Journal of Molecular Sciences, Acta Astronautica, RSC Advances, Frontiers in Cell and Developmental Biology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.